Comment: The route to global vaccine equity is not through the status quo | Business Post

‘The pharmaceutical industry sees a waiver as a frontal attack on a business model that has served them so well for decades.’ Picture: Getty

Mr Mallee brings up three well-rehearsed and equally well-debunked arguments: his first is that production is not the bottleneck for vaccine coverage; rather, the ability of what he calls “developing countries” to absorb and distribute these vaccines on the ground is the problem.

Secondly, the pandemic has provided ample evidence that geographically diverse pharmaceutical production is not just possible, it is in fact essential to safeguard citizens’ health everywhere. In Europe, for instance, the European Union are currently formulating an entire strategic approach to shorten pharmaceutical supply chains and boost local production as part of their Health Emergency Preparedness and Response Authority deliberations.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Irish companies in Russia; Sky enters mobile market; and more women needed in workforceBusiness Today: the best news, analysis and comment from The Irish Times business desk
مصدر: IrishTimesBiz - 🏆 6. / 77 اقرأ أكثر »